From: Clinical and neurocognitive outcome in symptomatic isovaleric acidemia
ID | Age at evaluation (y) | Psychomotor developmentb | IQ score | IQ testing toold |
---|---|---|---|---|
1 | 2.2 | Normal | NA | DDST |
2 | 3.8 | Mild retardation | NA | DDST |
3 | 5.3 | Normal | 108 | K-ABC |
4 | 6.1 | Normal | 106 | K-ABC |
5 | 6.5 | Normal | 116 | K-ABC |
6 | 7.1 | Normal | 108 | Kramer |
7 | 7.5 | Normal | 99 | K-ABC |
8 | 8.4 | Learning disability | 90 | K-ABC |
9 | 10.7 | Learning disability | 99 | K-ABC |
10 | 10.9 | Mild retardation | 67 | K-ABC |
11a | 11.5 | Normal | NA | NA |
12 | 11.6 | Normal | 118 | K-ABC |
13 | 14.2 | Learning disability | 85 | HAWIK-III |
14 | 15.4 | Normal | 116 | HAWIE-R |
15a | 16.5 | Learning disability | 93/94c, tested at age 8.5 y | CPM/CMMS |
16 | 19 | Normal | 119 | HAWIE-R |
17a | 20 | Normal | 101/91c, tested at age 11.6 y | SON/SPM |
18a | 20 | Normal, speech retardation at age 3.7 y | NA | NA |
19 | 24.4 | Normal | 122 | HAWIE-R |
20 | 25.3 | Severe retardation | 51/45c, tested at age 6.8 y | HAWIK/Kramer |